{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:55:22Z","timestamp":1790826922168,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.drugalcdep.2008.01.008","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T14:48:41Z","timestamp":1204901321000},"page":"140-146","source":"Crossref","is-referenced-by-count":74,"title":["Abuse liability assessment of atomoxetine in a drug-abusing population"],"prefix":"10.1016","volume":"95","author":[{"given":"Donald R.","family":"Jasinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Faries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Schuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2008.01.008_bib1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00097-8","article-title":"Guidelines and methodological reviews concerning drug abuse liability assessment","volume":"70","author":"Balster","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0893-133X(95)00113-R","article-title":"Evaluation of phentermine and fenfluramine alone and in combination, in normal, healthy volunteers","volume":"14","author":"Brauer","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib4","unstructured":"The National Center on Addiction and Substance Abuse (CASA) at Columbia University, 2005. Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S. CASA, New York."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib5","series-title":"Experimental Designs","author":"Cochran","year":"1957"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004714-199806000-00008","article-title":"Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines","volume":"18","author":"Cole","year":"1998","journal-title":"J Clin Psychopharm"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib7","doi-asserted-by":"crossref","unstructured":"Fischman, M.W., Mello, N.K., 1989. Testing for abuse liability of drugs in humans. NIDA Res. Monogr. 92, US DHHS Publication No. (ADM) 89-1613.","DOI":"10.1037\/e496492006-001"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib8","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1360-0443.1991.tb01758.x","article-title":"Methods for the assessment of abuse liability of psychomotor stimulants and anorectant agents in humans","volume":"86","author":"Foltin","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/sj.npp.1300593","article-title":"Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys","volume":"30","author":"Gasior","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib10","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0376-8716(03)00098-X","article-title":"Principles of initial experimental drug abuse liability assessment in humans","volume":"70","author":"Griffiths","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0376-8716(02)00053-4","article-title":"Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users","volume":"67","author":"Heil","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF02244241","article-title":"Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans","volume":"103","author":"Heishman","year":"1991","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","article-title":"An evaluation of the abuse potential of modafinil using methylphenidate as a reference","volume":"14","author":"Jasinski","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib14","first-page":"73","article-title":"Human abuse liability assessment by measurement of subjective and physiological effects","volume":"92","author":"Jasinski","year":"1989","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib15","series-title":"Proceedings of the 38th Meeting Minutes of the Committee on Problems of Drug Dependence","first-page":"112","article-title":"Progress report on studies from the clinical pharmacology section of the Addiction Research Center","author":"Jasinski","year":"1976"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib16","first-page":"676","article-title":"A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey","volume":"193","author":"Johanson","year":"1975","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib17","first-page":"341","article-title":"Drug abuse liability testing: human subject issues","volume":"92","author":"Kleber","year":"1989","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib18","first-page":"312","article-title":"Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys","volume":"254","author":"Kleven","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0091-3057(01)00464-6","article-title":"Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review","volume":"68","author":"Kollins","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1037\/1064-1297.14.2.136","article-title":"Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans","volume":"14","author":"Lile","year":"2006","journal-title":"Exp. Clin. Psychopharm."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","article-title":"Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man","volume":"12","author":"Martin","year":"1971","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1037\/0021-843X.112.3.497","article-title":"Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD","volume":"112","author":"Molina","year":"2003","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.151.4.781","article-title":"Intravenous methylphenidate abuse Prototype for prescription drug abuse","volume":"151","author":"Parran","year":"1991","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00429252","article-title":"Self-administration of CNS stimulants by dog","volume":"43","author":"Risner","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004714-200106000-00005","article-title":"Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans","volume":"21","author":"Rush","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426687","article-title":"Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man","volume":"53","author":"Smith","year":"1977","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib27","first-page":"53","article-title":"Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys","volume":"275","author":"Spealman","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/appi.ajp.163.3.387","article-title":"PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate","volume":"163","author":"Spencer","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1037\/1064-1297.13.1.56","article-title":"Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans","volume":"13","author":"Stoops","year":"2005","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib30","unstructured":"Strattera [Package Insert]. Indianapolis, IN, Eli Lilly and Company, 2007."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib31","first-page":"1041","article-title":"Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine","volume":"270","author":"Terry","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2004.03.010","article-title":"Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine","volume":"75","author":"Wee","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1056-4993(18)30108-1","article-title":"The stimulants revisited","volume":"9","author":"Wilens","year":"2000","journal-title":"Child. Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.drugalcdep.2008.01.008_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00401789","article-title":"Psychomotor stimulant self administration as a function of dosage per injection in the rhesus monkey","volume":"22","author":"Wilson","year":"1971","journal-title":"Psychopharmacologia"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871608000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871608000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:31:50Z","timestamp":1557336710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871608000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":34,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0376871608000446"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.01.008","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}